Recon: FDA advisors to discuss additional COVID boosters this week; Novartis restructuring aims to cut $1B, top execs ousted
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy